rs10772800

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_004963.4(GUCY2C):​c.2022C>T​(p.Ile674=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.962 in 1,613,586 control chromosomes in the GnomAD database, including 755,917 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.84 ( 57809 hom., cov: 30)
Exomes 𝑓: 0.97 ( 698108 hom. )

Consequence

GUCY2C
NM_004963.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.410
Variant links:
Genes affected
GUCY2C (HGNC:4688): (guanylate cyclase 2C) This gene encodes a transmembrane protein that functions as a receptor for endogenous peptides guanylin and uroguanylin, and the heat-stable E. coli enterotoxin. The encoded protein activates the cystic fibrosis transmembrane conductance regulator. Mutations in this gene are associated with familial diarrhea (autosomal dominant) and meconium ileus (autosomal recessive). [provided by RefSeq, Nov 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 12-14641128-G-A is Benign according to our data. Variant chr12-14641128-G-A is described in ClinVar as [Benign]. Clinvar id is 402916.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-14641128-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.41 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.982 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GUCY2CNM_004963.4 linkuse as main transcriptc.2022C>T p.Ile674= synonymous_variant 18/27 ENST00000261170.5 NP_004954.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GUCY2CENST00000261170.5 linkuse as main transcriptc.2022C>T p.Ile674= synonymous_variant 18/271 NM_004963.4 ENSP00000261170 P1

Frequencies

GnomAD3 genomes
AF:
0.843
AC:
128078
AN:
151976
Hom.:
57806
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.481
Gnomad AMI
AF:
0.976
Gnomad AMR
AF:
0.936
Gnomad ASJ
AF:
0.966
Gnomad EAS
AF:
0.989
Gnomad SAS
AF:
0.977
Gnomad FIN
AF:
0.988
Gnomad MID
AF:
0.965
Gnomad NFE
AF:
0.989
Gnomad OTH
AF:
0.880
GnomAD3 exomes
AF:
0.950
AC:
238744
AN:
251312
Hom.:
115493
AF XY:
0.960
AC XY:
130356
AN XY:
135816
show subpopulations
Gnomad AFR exome
AF:
0.466
Gnomad AMR exome
AF:
0.973
Gnomad ASJ exome
AF:
0.970
Gnomad EAS exome
AF:
0.989
Gnomad SAS exome
AF:
0.980
Gnomad FIN exome
AF:
0.988
Gnomad NFE exome
AF:
0.988
Gnomad OTH exome
AF:
0.970
GnomAD4 exome
AF:
0.974
AC:
1423538
AN:
1461492
Hom.:
698108
Cov.:
42
AF XY:
0.976
AC XY:
709428
AN XY:
727050
show subpopulations
Gnomad4 AFR exome
AF:
0.459
Gnomad4 AMR exome
AF:
0.969
Gnomad4 ASJ exome
AF:
0.971
Gnomad4 EAS exome
AF:
0.989
Gnomad4 SAS exome
AF:
0.980
Gnomad4 FIN exome
AF:
0.988
Gnomad4 NFE exome
AF:
0.989
Gnomad4 OTH exome
AF:
0.953
GnomAD4 genome
AF:
0.842
AC:
128105
AN:
152094
Hom.:
57809
Cov.:
30
AF XY:
0.846
AC XY:
62942
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.480
Gnomad4 AMR
AF:
0.936
Gnomad4 ASJ
AF:
0.966
Gnomad4 EAS
AF:
0.989
Gnomad4 SAS
AF:
0.977
Gnomad4 FIN
AF:
0.988
Gnomad4 NFE
AF:
0.989
Gnomad4 OTH
AF:
0.881
Alfa
AF:
0.963
Hom.:
129414
Bravo
AF:
0.824
Asia WGS
AF:
0.948
AC:
3296
AN:
3478
EpiCase
AF:
0.988
EpiControl
AF:
0.987

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Congenital diarrhea 6 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
8.6
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10772800; hg19: chr12-14794062; API